Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]

Detalles Bibliográficos
Autores principales: Shalaby, Mohammed Fouad, Abd El Latif, Hekma A., Yamani, Mohamed El, Galal, May Ahmed, Kamal, Sherifa, Sindi, Ikhlas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846453/
https://www.ncbi.nlm.nih.gov/pubmed/36685732
http://dx.doi.org/10.1016/j.curtheres.2022.100664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846453/
https://www.ncbi.nlm.nih.gov/pubmed/36685732
http://dx.doi.org/10.1016/j.curtheres.2022.100664

Ejemplares similares